Wa'el Hashad Wa'el Hashad, CEO, Longeveron Full enrollment achieved for pivotal Phase 2b clinical trial (ELPIS II) evaluating ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the second quarter ended June 30, 2025.

From lifting military aid restrictions to delisting Baloch insurgents, Trump extended key political and security concessions ...

Key Points Net loss (GAAP) narrowed to $23.5 million, with operating expenses reduced by 30.6% for the three months ended June 30, 2025, compared to 2024. No revenue was reported for the second ...

Pakistan and the US have agreed to deepen bilateral cooperation to tackle leading militant groups, including the Balochistan ...